Literature DB >> 1995762

A form of familial hypobetalipoproteinaemia not due to a mutation in the apolipoprotein B gene.

S Fazio1, A Sidoli, A Vivenzio, A Maietta, S Giampaoli, A Menotti, R Antonini, G Urbinati, F E Baralle, G Ricci.   

Abstract

Familial hypobetalipoproteinaemia (FHBL) is a dominant disorder of lipoprotein metabolism characterized by levels of apolipoprotein B-carrying lipoproteins (VLDL, IDL and LDL) which are 50% of the normal levels in the heterozygotes and almost absent in the homozygotes. Several reports have recently shown that the underlying defect in FHBL involves different mutations in the apo B gene which lead to reduced levels of apo B mRNA or to the production of truncated forms of apo B having either a lower synthetic rate or a higher catabolic rate than normal apo B. We here present a three-generation family with several FHBL members in which the linkage analysis shows absence of co-segregation between apo B gene alleles and the hypocholesterolaemic phenotype. We conclude that a dominantly transmitted mutation in a gene other than that for apo B is responsible for the low plasma cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1995762     DOI: 10.1111/j.1365-2796.1991.tb00304.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

1.  Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.

Authors:  Sergio Fazio; Jessica Minnier; Michael D Shapiro; Sotirios Tsimikas; Patrizia Tarugi; Maurizio R Averna; Marcello Arca; Hagai Tavori
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

Review 2.  Update on primary hypobetalipoproteinemia.

Authors:  Amanda J Hooper; John R Burnett
Journal:  Curr Atheroscler Rep       Date:  2014-07       Impact factor: 5.113

3.  Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.

Authors:  Ilenia Minicocci; Anna Montali; Marius Robert Robciuc; Fabiana Quagliarini; Vincenzo Censi; Giancarlo Labbadia; Claudia Gabiati; Giovanni Pigna; Maria Laura Sepe; Fabio Pannozzo; Dieter Lütjohann; Sergio Fazio; Matti Jauhiainen; Christian Ehnholm; Marcello Arca
Journal:  J Clin Endocrinol Metab       Date:  2012-06-01       Impact factor: 5.958

4.  Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22.

Authors:  B Yuan; R Neuman; S H Duan; J L Weber; P Y Kwok; N L Saccone; J S Wu; K Y Liu; G Schonfeld
Journal:  Am J Hum Genet       Date:  2000-04-10       Impact factor: 11.025

Review 5.  Angiopoietin-like 3 in lipoprotein metabolism.

Authors:  Sander Kersten
Journal:  Nat Rev Endocrinol       Date:  2017-10-06       Impact factor: 43.330

Review 6.  Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.

Authors:  Kelli L Sylvers-Davie; Brandon S J Davies
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-08-02       Impact factor: 5.900

Review 7.  Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia.

Authors:  Pei-Yi Chen; Wan-Yun Gao; Je-Wen Liou; Ching-Yen Lin; Ming-Jiuan Wu; Jui-Hung Yen
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.